Definitive Healthcare (DH) to Release Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is projected to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $60.60 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Definitive Healthcare Stock Performance

NASDAQ:DH opened at $4.97 on Wednesday. Definitive Healthcare has a 1 year low of $3.19 and a 1 year high of $10.62. The firm has a 50 day moving average of $4.62 and a 200-day moving average of $4.47. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $574.13 million, a P/E ratio of -1.60, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Stephens initiated coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Finally, Barclays restated an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a research report on Monday, January 13th. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Definitive Healthcare presently has a consensus rating of “Hold” and a consensus target price of $5.72.

Insider Buying and Selling at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 14.84% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.